Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular characterization of HIV type 1 in Brazzaville, Republic of Congo, and first data on resistance to antiretroviral drugs.

AIDS research and human retroviruses - 1 Dec 2012

Pircher Mathilde, Diafouka Merlin, Papuchon Jennifer, Recordon-Pinson Patricia, Mahambou Dominique Nsonde, Akolbout Maryse, Simon Bernard, Fleury Hervé

Abstract excerpt

One hundred patients have been enrolled in the CTA (ambulatory treatment center) of Brazzaville, Republic of Congo, from February to April 2011: 41 naive individuals and 59 patients at failure of first line regimen [two nucleoside reverse transcriptase inhibitors (NRTIs) plus one nonnucleoside reverse transcriptase inhibitor (NNRTI)]. Phylogenetic analysis of HIV-1 isolates allowed identification of subtypes and...

Topics

Join the communities discussing this publication.

Anti-Retroviral Agents
Cluster Analysis
Congo
Drug Resistance, Viral
HIV-1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

HIV Reverse Transcriptase

Source

Identifiers

PMID: 22697883
DOI: 10.1089/aid.2012.0083

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular characterization of HIV type 1 in Brazzaville, Republic of Congo, and first data on resistance to antiretroviral drugs.PMID 22697883Read ↗

HIV-1 genetic diversity and primary drug resistance mutations before large-scale access to antiretroviral therapy, Republic of Congo.Semantic proximity Read ↗

Resistance to antiretroviral drugs in treated and drug-naive patients in the Democratic Republic of Congo.Semantic proximity Read ↗

High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in Cuba.Semantic proximity Read ↗

Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.Semantic proximity Read ↗

Prevalence of HIV-1 Subtypes and Drug Resistance-Associated Mutations in HIV-1-Positive Treatment-Naive Pregnant Women in Pointe Noire, Republic of the Congo (Kento-Mwana Project).Semantic proximity Read ↗

HIV-1 subtypes and recombinants in the Republic of Congo.Semantic proximity Read ↗

Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study.Semantic proximity Read ↗

Epidemiological and virological characteristics of people living with HIV on antiretroviral treatment for more than six months in virological failure in Brazzaville, Republic of CongoSemantic proximity Read ↗

HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC).Semantic proximity Read ↗

New Genomes from the Congo Basin Expand History of CRF01_AE Origin and Dissemination.Semantic proximity Read ↗

Structural Features and Genetic Diversity in Gag Gene of Rare HIV-1 Subtypes from the Democratic Republic of Congo.Semantic proximity Read ↗

Genotypic resistance to antiretroviral drugs in patients infected with several HIV type 1 genetic forms in Cuba.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.